Partial
Partially Aligned
Patient Risk:
Low
Summary
The supplied label sections support caution with anticoagulants and generally discourage concomitant ibuprofen and aspirin, but do not substantiate most onset, formulation, food, headache-response, dosing, ulcer-history, or kidney-disease claims. Absence from these excerpts does not establish that those claims are false.
Category Scores
Accurate Statements
Caution is advised with ibuprofen in people taking blood thinners.
The label advises caution when administering ibuprofen to patients on anticoagulants and notes that warfarin and NSAIDs together increase the risk of serious gastrointestinal bleeding.
Ibuprofen should not be combined with other NSAIDs, such as naproxen or aspirin taken for pain, unless a clinician advises it.
Partially supported: the label says concomitant ibuprofen and aspirin is not generally recommended because of potential increased adverse effects. The supplied excerpt does not address naproxen or the stated clinician-advice exception.
Caution is advised with ibuprofen in people who have been told to avoid NSAIDs.
Partially supported for patients with asthma, urticarial, or allergic-type reactions after aspirin or other NSAIDs, for whom ibuprofen is contraindicated. The supplied section does not establish a general caution for everyone advised to avoid NSAIDs.
Unsupported Statements
For most people, oral ibuprofen starts to work within about 30 to 60 minutes; pain relief often becomes more noticeable within the first hour; some people may need closer to 1 to 2 hours for full effect.
The supplied label sections do not describe onset or time to full pain-relief effect.
The dose and formulation can affect how quickly ibuprofen works; liquid-gel ibuprofen may act faster than tablets.
The supplied sections do not compare dose or formulation effects on onset, or compare liquid-gel and tablet formulations.
Having a full stomach can slow ibuprofen absorption.
The supplied sections do not discuss food or absorption.
Headache type can affect onset; tension-type headaches respond steadily, while migraines may have different response timing.
The supplied sections do not discuss headache types or treatment-response timing.
Individual metabolism and sensitivity to ibuprofen can affect how quickly it works.
The supplied sections do not address individual differences in onset.
Taking more ibuprofen sooner than the product label allows can increase side-effect risk, and ibuprofen should be taken according to the product label's dosing instructions and maximum daily amount.
The supplied sections contain no dosing schedule, maximum daily amount, or instructions about taking more than directed.
Caution is advised with ibuprofen in people with a history of stomach ulcers or bleeding.
The supplied excerpt mentions increased gastrointestinal bleeding risk with concurrent anticoagulants, but does not address a patient's history of ulcers or bleeding.
Caution is advised with ibuprofen in people with kidney disease.
The supplied excerpt advises observation for renal failure during concomitant NSAID and diuretic therapy; it does not make a general statement about people with kidney disease.
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
No claim directly contradicts the supplied label excerpts. The excerpts do not verify several timing and dosing statements; the interaction caution for anticoagulants is supported.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
Most onset, dosing, food-effect, and headache-response claims are not supported by the supplied label sections.
Suggested Improvement
Limit label-based statements to what these excerpts establish, and distinguish supported anticoagulant and aspirin cautions from claims not addressed in the supplied sections.